MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Colleagues,

As reported in Silicon Valley Business Journal ... GE Healthcare is investing $5 million in CardioDx, Inc. as part of a strategic alliance with the Palo Alto, Ca. diagnostic test developer.

GE Healthymagination Fund, a new equity fund for health care technology companies, made the investment as part of a potential $44.5 million Series D financing round undertaken by CardioDx...


... GE says it plans to invest $3 billion over five years in health care technologies and
biotech.

CardioDX, founded in early 2005 and led by President and CEO David Levison, a year ago started marketing its Corus CAD test. That is shoebox-size kit that uses a two-teaspoon draw of blood to test for obstructive coronary disease...


... CardioDx’s lab runs the blood across 23 genes in its algorithm and reports back with a score — from zero to 40 — that translates into the likelihood of a patient having heart disease.



Views: 17

© 2021   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service